Align Technology, Inc. $ALGN Shares Sold by Amundi

Key Points

• Amundi cut its Align Technology stake by 36%. The firm sold 201,510 shares during the first quarter and retained 358,728 shares valued at approximately $61.5 million; institutional investors and hedge funds own 88.43% of the stock.
• Align exceeded second-quarter expectations. The company reported adjusted earnings of $2.64 per share and revenue of $1.06 billion, up 4.3% year over year, supported by record Clear Aligner shipments and improved margins.
• Growth prospects remain mixed. Management reaffirmed its 2026 outlook and is emphasizing digital orthodontics, but softer systems demand, pricing pressure and modest revenue growth remain concerns; analysts have a “Moderate Buy” consensus with an average $206.36 price target.

Amundi reduced its stake in shares of Align Technology, Inc. (NASDAQ:ALGN - Free Report) by 36.0% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 358,728 shares of the medical equipment provider's stock after selling 201,510 shares during the period. Amundi owned 0.50% of Align Technology worth $61,497,000 as of its most recent SEC filing.

Several other hedge funds have also modified their holdings of the stock. Capital International Investors raised its position in shares of Align Technology by 52.2% in the 4th quarter. Capital International Investors now owns 4,643,221 shares of the medical equipment provider's stock worth $725,039,000 after buying an additional 1,592,848 shares during the period. Ruane Cunniff & Goldfarb L.P. purchased a new position in shares of Align Technology in the 4th quarter worth about $190,899,000. Norges Bank acquired a new position in shares of Align Technology in the 4th quarter valued at about $155,556,000. Assenagon Asset Management S.A. grew its holdings in shares of Align Technology by 413.0% during the 1st quarter. Assenagon Asset Management S.A. now owns 989,388 shares of the medical equipment provider's stock worth $169,611,000 after purchasing an additional 796,529 shares during the period. Finally, Arrowstreet Capital Limited Partnership grew its holdings in shares of Align Technology by 247.3% during the 4th quarter. Arrowstreet Capital Limited Partnership now owns 1,005,413 shares of the medical equipment provider's stock worth $156,995,000 after purchasing an additional 715,919 shares during the period. 88.43% of the stock is owned by institutional investors and hedge funds.

Key Align Technology News

Here are the key news stories impacting Align Technology this week:

• Positive Sentiment: Q2 results exceeded expectations. Align reported adjusted earnings of $2.64 per share and revenue of approximately $1.06 billion, topping consensus estimates. Revenue increased 4.3% year over year, while record Clear Aligner shipments and improved non-GAAP margins supported profitability. Align Technology Q2 Earnings and Revenues Top Estimates
• Positive Sentiment: Digital orthodontics remains a growth focus. Management highlighted expanding digital workflows, connected orthodontic tools and long-term opportunities for Invisalign, iTero scanners and exocad software. The company’s 2026 outlook was reaffirmed, while an orthodontic summit showcased its product and technology strategy. ALGN Q2 Earnings Call Highlights Digital Growth Push
• Positive Sentiment: Board changes could improve shareholder value. Following discussions with Elliott Investment Management, Align plans to add three independent directors and conduct an operational review. The initiatives may increase accountability, improve execution and identify opportunities to enhance returns. Align Technology to Overhaul Board Following Engagement with Elliott
• Neutral Sentiment: Valuation is viewed as more attractive after the pullback. Some analysts see ALGN as reasonably valued, but believe the stock needs faster growth to generate sustained upside. Align Technology: Attractively Valued, But Growth Still Needs To Pick Up
• Negative Sentiment: Near-term guidance and execution remain concerns. Third-quarter revenue guidance of roughly $1.0 billion was described as slightly below or around expectations, limiting the benefit of the earnings beat.
• Negative Sentiment: Systems weakness is capping upside. Analysts noted softer scanner and systems performance, along with pricing pressure, despite strong Clear Aligner volumes. Needham maintained a Hold rating. Align Technology Hold Rating Maintained
• Negative Sentiment: Growth is still relatively modest. Investors may remain cautious because revenue growth has not yet accelerated enough to justify a more bullish outlook, even with improving margins and record aligner shipments.

Analyst Ratings Changes

Several research analysts recently commented on the stock. UBS Group restated a "neutral" rating and issued a $189.00 price target on shares of Align Technology in a report on Thursday, July 23rd. Morgan Stanley increased their price objective on shares of Align Technology from $169.00 to $188.00 and gave the stock an "equal weight" rating in a research report on Friday, April 24th. Citigroup began coverage on shares of Align Technology in a research note on Wednesday, April 15th. They issued a "buy" rating and a $240.00 target price on the stock. Needham & Company LLC reaffirmed a "hold" rating on shares of Align Technology in a research report on Thursday. Finally, Weiss Ratings upgraded Align Technology from a "hold (c-)" rating to a "hold (c)" rating in a report on Friday, July 17th. One equities research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and six have issued a Hold rating to the stock. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and an average target price of $206.36.

Align Technology Price Performance

Shares of Align Technology stock opened at $169.16 on Monday. Align Technology, Inc. has a 1-year low of $122.00 and a 1-year high of $200.43. The company has a market capitalization of $12.12 billion, a PE ratio of 29.42, a P/E/G ratio of 1.78 and a beta of 1.65. The business has a 50-day moving average of $174.55 and a 200-day moving average of $175.23.

Align Technology (NASDAQ:ALGN - Get Free Report) last issued its quarterly earnings results on Wednesday, July 29th. The medical equipment provider reported $2.64 EPS for the quarter, beating analysts' consensus estimates of $2.62 by $0.02. Align Technology had a return on equity of 15.86% and a net margin of 9.99%.The firm had revenue of $1.06 billion during the quarter, compared to the consensus estimate of $1.05 billion. During the same quarter in the prior year, the business posted $2.49 earnings per share. Align Technology's revenue for the quarter was up 4.3% on a year-over-year basis. On average, equities analysts expect that Align Technology, Inc. will post 9.48 earnings per share for the current fiscal year.

Align Technology declared that its Board of Directors has authorized a stock buyback program on Wednesday, April 29th that authorizes the company to buyback $200.00 million in shares. This buyback authorization authorizes the medical equipment provider to purchase up to 1.6% of its shares through open market purchases. Shares buyback programs are generally an indication that the company's board of directors believes its shares are undervalued.

Align Technology Profile

Align Technology, Inc NASDAQ: ALGN pioneered the use of digital technology in orthodontics through the development of the Invisalign system, a series of clear, removable aligners that provide an alternative to traditional metal braces. Since its founding in 1997 by Zia Chishti and Kelsey Wirth, the Tempe, Arizona–based company has expanded its focus to include intraoral scanners, CAD/CAM software for dental laboratories and comprehensive digital dentistry solutions.

The company's signature Invisalign system leverages 3D imaging and computer-aided design (CAD) to create customized aligners that gradually reposition teeth, improving patient comfort and treatment predictability.

Want to see what other hedge funds are holding ALGN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Align Technology, Inc. (NASDAQ:ALGN - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source